University of California San Francisco

Peter A. Schneider
Peter
Schneider
MD

Professor of Surgery
Division of Vascular & Endovascular Surgery
Department of Surgery, School of Medicine
University of California, San Francisco

Academic Office:
400 Parnassus Ave, A581, Box 0222
San Francisco, CA 94143
Tel: 415-353-4366
Email: peter.schneider@ucsf.edu 
Asst: matt.kuhn@ucsf.edu

Vascular Surgery Clinic at SFVA:
4150 Clement Street, 
San Francisco, CA 94121
Tel: 415-221-4810 x25496 

Biography

Dr. Peter A. Schneider is a vascular surgeon with expertise in treating a broad range of conditions involving the blood vessels, including carotid artery disease, diabetic vascular disease and thoracic aortic aneurysm.

Schneider's participation in vascular disease research over the past 25 years has included designing trials to evaluate new treatments, providing oversight, analyzing data, presenting findings and publishing results. He has served as principal investigator for numerous national clinical trials. He has consulted on trials to show efficacy and gain regulatory approval for many vascular devices, met with the Food and Drug Administration (FDA) and testified at FDA panel hearings. His experience also includes performing procedures for several first-in-human trials.

Schneider earned his medical degree from the Johns Hopkins School of Medicine and completed a residency in general surgery and a fellowship in vascular surgery at UCSF. Before joining the UCSF faculty, he was the founding member and chief of Kaiser Permanente Hawaii's vascular surgery division. At Kaiser, he developed an aneurysm screening and monitoring program and a registry for patients with carotid artery disease. He oversaw development of the Kaiser system's first operating room for endovascular surgery (less invasive procedures to repair blood vessels).

Schneider has served as president of the Western Vascular Society and on many committees of the Society for Vascular Surgery. He is a fellow of the American College of Surgeons, distinguished fellow of the Society for Vascular Surgery and fellow of the International Society of Vascular Surgery. He has authored several textbooks, including the fourth edition of Endovascular Skills: Guidewire and Catheter Skills for Endovascular Surgery, as well as more than 100 articles in peer-reviewed journals. He founded two medical device companies, has served as an adviser to many others and holds numerous patents.

Education

Institution Degree Dept or School End Date
UCSF Fellowship Vascular Surgery 1991
UCSF Residency General Surgery 1989
Johns Hopkins University School of Medicine MD 1983

Board Certifications

American Board of Surgery, Vascular Surgery

Clinical Expertise

Abdominal Aortic Aneurysm
Carotid Artery Disease
Complex Limb Revascularization
Critical Limb Ischemia
Diabetic Vascular Disease
Dialysis Access
Endovascular Aneurysm Repair
Mesenteric Artery Disease
Peripheral Artery Disease
Thoracic Aortic Aneurysm
Thoracic Outlet Syndrome

Research Narrative

Dr. Schneider has served as National Principal Investigator for numerous clinical trials. Over 25 years, he has been a strong proponent of clinical research in vascular disease and has participated extensively in trial design, oversight, core lab analysis, events committees, data analysis, follow up, presentation, and publication. He has consulted on the regulatory pathway and pivotal trials for many vascular devices, has participated in numerous meetings with the FDA and has testified at FDA panel hearings. His experience includes performing procedures for several first-in-human trials. 

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 148
  1. A First-in-Human Evaluation of a Novel Mesh-Covered Stent for Treatment of Carotid Stenosis in Patients at High Risk for Endarterectomy: 30-Day Results of the SCAFFOLD Trial.
    Schneider PA, Levy E, Bacharach JM, Metzger DC, Randall B, Garcia A, Siddiqui A, Schonholz C, Gray W| | PubMed
  2. Centers for Medicare & Medicaid Services' decision on drug-coated balloons: No additional reimbursement despite higher cost and highest levels of scientific evidence.
    Shishehbor MH, White CJ, Beckman JA, Misra S, Schneider PA, Lookstein RA, Kashyap VS, Clair D, Jones WS, Rosenfield K, Katzen BT, Jaff MR| | PubMed
  3. Response by Schneider et al to Letter Regarding Article, "Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial".
    Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, Metzger C, Micari A, Sachar R, Jaff MR, Wang H, Hasenbank MS, Krishnan P, IN.PACT SFA Trial Investigators| | PubMed
  4. Treatment of infrapopliteal post-PTA dissection with tack implants: 12-month results from the TOBA-BTK study.
    Brodmann M, Wissgott C, Holden A, Staffa R, Zeller T, Vasudevan T, Schneider P| | PubMed
  5. Public Health Impact of the Centers for Medicare and Medicaid Services Decision on Pass-Through Add-On Payments for Drug-Coated Balloons: A Call to Action.
    Shishehbor MH, Jaff MR, Beckman JA, Misra S, Schneider PA, Lookstein R, Kashyap VS, Aronow HD, Jones WS, White CJ| | PubMed
  6. Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial.
    Schneider PA, Laird JR, Tepe G, Brodmann M, Zeller T, Scheinert D, Metzger C, Micari A, Sachar R, Jaff MR, Wang H, Hasenbank MS, Krishnan P, IN.PACT SFA Trial Investigators| | PubMed
  7. Novel Nitinol Stent for Lesions up to 24 cm in the Superficial Femoral and Proximal Popliteal Arteries: 24-Month Results From the TIGRIS Randomized Trial.
    Laird JR, Zeller T, Loewe C, Chamberlin J, Begg R, Schneider PA, Nanjundappa A, Bunch F, Schultz S, Harlin S, Lansky A, Jaff MR| | PubMed
  8. Evolution and current use of technology for superficial femoral and popliteal artery interventions for claudication.
    Schneider PA| | PubMed
  9. Carotid artery stenting should remain an alternative to endarterectomy in selected patients.
    Schneider PA| | PubMed
  10. How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.
    Vogler S, Paris V, Ferrario A, Wirtz VJ, de Joncheere K, Schneider P, Pedersen HB, Dedet G, Babar ZU| | PubMed